BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNR
2726
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $22.8M | ﹤0.01% |
6,308,376
-301,369
| -5% | -$908K |
|
2727
Vishay Precision Group
VPG
$908M
| $22.7M | ﹤0.01% |
922,595
+127,175
| +16% | +$2.86M |
|
2728
Cytosorbents Corp
CTSO
$22.8M
| $22.6M | ﹤0.01% |
2,285,783
+189,135
| +9% | +$1.74M |
|
2729
Blue Bird Corp
BLBD
$2.05B
| $22.5M | ﹤0.01% |
1,501,184
-4,817
| -0.3% | -$60.4K |
|
2730
PUT
American Airlines Group
AAL
$9.97B
| $22.4M | ﹤0.01% |
+1,715,000
| New | +$20.8M |
|
2731
Smith & Nephew
SNN
$12.6B
| $22.3M | ﹤0.01% |
584,939
-785,344
| -57% | -$31.1M |
|
2732
Lennar Class B
LEN.B
$20.7B
| $22.3M | ﹤0.01% |
508,759
+32,886
| +7% | +$1.24M |
|
2733
Astronics
ATRO
$4.57B
| $22.2M | ﹤0.01% |
2,523,041
+245,741
| +11% | +$1.92M |
|
|
WTRE
2734
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $22.1M | ﹤0.01% |
1,325,213
-11,505
| -0.9% | -$165K |
|
|
TRUE
2735
DELISTED
TrueCar
TRUE
| $21.9M | ﹤0.01% |
8,502,598
+531,356
| +7% | +$1.36M |
|
|
AFMD
2736
DELISTED
Affimed
AFMD
| $21.9M | ﹤0.01% |
475,316
+29,098
| +7% | +$810K |
|
2737
Tejon Ranch
TRC
$443M
| $21.9M | ﹤0.01% |
1,517,724
-240
| -0% | -$3.34K |
|
2738
Sterling Infrastructure
STRL
$16.9B
| $21.8M | ﹤0.01% |
2,085,713
+138,830
| +7% | +$1.28M |
|
2739
Byline Bancorp
BY
$1.78B
| $21.8M | ﹤0.01% |
1,664,984
+11,164
| +0.7% | +$128K |
|
|
VEDL
2740
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $21.8M | ﹤0.01% |
3,880,777
+19,115
| +0.5% | +$90.4K |
|
2741
Energy Recovery
ERII
$399M
| $21.8M | ﹤0.01% |
2,864,872
+31,623
| +1% | +$250K |
|
2742
Expro Ltd
XPRO
$2.1B
| $21.7M | ﹤0.01% |
1,622,649
+360,777
| +29% | +$4.86M |
|
|
ORBC
2743
DELISTED
ORBCOMM, Inc.
ORBC
| $21.7M | ﹤0.01% |
5,631,276
+45,742
| +0.8% | +$137K |
|
2744
HF Foods Group
HFFG
$97.6M
| $21.7M | ﹤0.01% |
2,393,736
+776,486
| +48% | +$5.65M |
|
2745
CALL
L3Harris
LHX
$53.7B
| $21.6M | ﹤0.01% |
127,600
-3,900
| -3% | -$733K |
|
|
AIZP
2746
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
| $21.6M | ﹤0.01% |
207,822
-7,398
| -3% | -$779K |
|
2747
Seres Therapeutics
MCRB
$45M
| $21.6M | ﹤0.01% |
226,664
+29,255
| +15% | +$2.57M |
|
|
PRVL
2748
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $21.6M | ﹤0.01% |
1,446,343
+312,364
| +28% | +$4.81M |
|
2749
Endava
DAVA
$167M
| $21.5M | ﹤0.01% |
445,728
+4,190
| +0.9% | +$187K |
|
2750
iShares US Financial Services ETF
IYG
$2.24B
| $21.5M | ﹤0.01% |
+540,474
| New | +$20.8M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.